SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-08-007218
Filing Date
2008-02-08
Accepted
2008-02-08 17:26:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 v102647_sc13d-a.htm SC 13D/A 56871
  Complete submission text file 0001144204-08-007218.txt   58580
Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address C/O PARAMONT CAPITAL INC 787 SEVENTH AVENE 44TH FL NEW YORK NY 10019 2125315965
WEISS MICHAEL S (Filed by) CIK: 0001038977 (see all company filings)

Type: SC 13D/A

Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-78786 | Film No.: 08590408
SIC: 2834 Pharmaceutical Preparations